is it dangerous to take glp 1 The Benefits of GLP-1 Therapy: Beyond Weight Loss How Do You Know When

Participants receiving semaglutide showed nearly a 50% reduction in alcohol consumptionan effect size equal to or greater than seen with FDA-approved medications for AUD, like naltrexone, acamprosate, and disulfiram

20 GilbertMPPratleyRE

Clinical data on tirzepatide in type 2 diabetesthe SURPASS clinical trial program Early clinical studies with tirzepatide revealed a marked and dose-dependent reduction of HbA1c and further glycemic parameters in patients with T2D in various ethnic cohorts (clinical trials registration numbers NCT03322631, NCT03131687, and NCT03311724) (6668)

The latest study to see this effect was presented Sunday at the annual meeting of the European Congress on Obesity and published in the New England Journal of Medicine